The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes
Open accessAbstract
Leber's Hereditary Optic Neuropathy (LHON) was the first maternally inherited mitochondrial disease identified and is now considered the most prevalent mitochondrial disorder. LHON patients harbor mutations in mitochondrial DNA (mtDNA). In about 90% of cases, the genes involved encode proteins of the respiratory chain complex I. Even though the molecular bases are known since 20 years almost all remains to be done regarding physiopathology and therapy. In this study, we report a severe decrease of complex I activity in cultured skin fibroblasts isolated from two LHON patients harboring mutations in ND4 or ND1 genes. Most importantly, we were able to restore sustainably (a) the ability to grow on galactose, (b) the ATP synthesis rate and (c) the complex I activity, initially impaired in these cells. Our strategy consisted of forcing mRNAs from nuclearly-encoded ND1 and ND4 genes to localize to the mitochondrial surface. The rescue of the respiratory chain defect observed was possible by discreet amounts of hybrid mRNAs and fusion proteins demonstrating the efficiency of their mitochondrial import. Hence, we confirmed here for two mitochondrial genes located in the organelle that the optimized allotopic expression approach represents a powerful tool that could ultimately be applied in human therapy for LHON.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of the transgene results in the synthesis of a functional human ND4 protein that translocates into the mitochondrial compartment.”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This strategy has been successfully applied in cell models and safely translated in induced rodent LHON models with preservation of RGCs and visual function.9–12”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chrétien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J., & Münnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,265
Self-citationLeber hereditary optic neuropathy
Man, P. Y. W., Turnbull, D. M., & Chinnery, P. F. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.162 · Cited by 520
Characterization of Superoxide-producing Sites in Isolated Brain Mitochondria
Kudin, A. P., Bimpong‐Buta, N., Vielhaber, S., Elger, C. E., & Kunz, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310341200 · Cited by 514
Prevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Blue Native electrophoresis to study mitochondrial and other protein complexes
Nijtmans, L. G. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00038-5 · Cited by 366
An ND-6 mitochondrial DNA mutation associated with leber hereditary optic neuropathy
Johns, D. R., Neufeld, M. J., & Park, R. D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90479-5 · Cited by 349
Brown, M. D., Trounce, I. A., Jun, A. S., Allen, J. C., & Wallace, D. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006476200 · Cited by 260
Analysis of the Assembly Profiles for Mitochondrial- and Nuclear-DNA-Encoded Subunits into Complex I
Lazarou, M., McKenzie, M., Ohtake, A., Thorburn, D. R., & Ryan, M. T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00074-07 · Cited by 254
Howell, N., Kubacka, I., Xu, M., & McCullough, D. A. (1991) · PubMed · Cited by 237
Cited by
Sorted by citations
Mitochondrial DNA mutations and human disease
Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M., & Taylor, R. W. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.09.005 · Cited by 676
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
Self-citationEllouze, S., Augustin, S., Bouaita, A., Bonnet, C., Simonutti, M., Forster, V., Picaud, S. A., Sahel, J., & Corral‐Debrinski, M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.013 · Cited by 224
Self-citationVector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 191
Emerging therapies for mitochondrial diseases
Hirano, M., Emmanuele, V., & Quinzii, C. M. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170114 · Cited by 167
Perales‐Clemente, E., Fernández‐Silva, P., Acín‐Pérez, R., Martos, A. P., & Enríquez, J. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq769 · Cited by 156
Let There Be Light: Gene and Cell Therapy for Blindness
Dalkara, D., Goureau, O., Marazova, K., & Sahel, J. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.147 · Cited by 141
Self-citationEmerging concepts in the therapy of mitochondrial disease
Viscomi, C. F., Bottani, E., & Zeviani, M. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.03.001 · Cited by 109
Koilkonda, R. D., Yu, H., Chou, T.-H., Feuer, W. J., Ruggeri, M., Porciatti, V., Tse, D., Hauswirth, W. W., Chiodo, V. A., Boye, S. L., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7630 · Cited by 103
DiMauro, S., & Rustin, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.015 · Cited by 94
Self-citationTherapeutic Options in Hereditary Optic Neuropathies
Amore, G., Romagnoli, M., Carbonelli, M., Barboni, P., Carelli, V., & Morgia, C. L. (2020) · Drugs · doi:10.1007/s40265-020-01428-3 · Cited by 96
Gene therapy for inherited retinal and optic nerve degenerations
Moore, N. A., Morral, N., Ciulla, T. A., & Bracha, P. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1389886 · Cited by 91
Marella, M., Seo, B. B., Thomas, B. B., Matsuno‐Yagi, A., & Yagi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011472 · Cited by 92
Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy
Newman, N. J., Yu-Wai-Man, P., Subramanian, P. S., Moster, M. L., Wang, A.-G., Donahue, S. P., Leroy, B. P., Carelli, V., Biousse, V., Vignal-Clermont, C., et al. (2023) · Brain · doi:10.1093/brain/awac421 · Cited by 87
“struct includes the cis-acting elements of the human cytochrome c oxidase 10 (COX10) mtRNA (MTS in 5′ of the cDNA, and 3′ UTR at the 3′ end of the cDNA) ensuring the efficient delivery of the corresponding hybrid mRNA to the mitochondrial surface.(12,13)”
Self-citationCwerman-Thibault, H., Augustin, S., Lechauve, C., Ayache, J., Ellouze, S., Sahel, J.-A., & Corral-Debrinski, M. (2015) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2015.3 · Cited by 86
Self-citationMitochondrial medicine: entering the era of treatment
Koene, S., & Smeitink, J. A. M. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02058.x · Cited by 82
Intracellular organelle-targeted non-viral gene delivery systems
Won, Y.-W., Lim, K. S., & Kim, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.013 · Cited by 75
Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
“As delivering genes into the ganglion cell mitochondria is difficult, “allotopic expression” strategy (mitochondrial gene expression in nucleus) has been developed.(61) Different trials have demonstrated the safety and efficacy of gene therapy using an AAV vector, delivered through an intravitreal route, for LHON.”
BackgroundBiousse, V., Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Vignal-Clermont, C., Klopstock, T., Sadun, A. A., Sergott, R. C., Hage, R., et al. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001367 · Cited by 78
Self-citationClinical trials in mitochondrial disorders, an update
Almannai, M., El‐Hattab, A. W., Ali, M. N., Soler‐Alfonso, C., & Scaglia, F. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.10.002 · Cited by 75
Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer's disease in Han Chinese
Bi, R., Zhang, W., Yu, D., Li, X., Wang, H.-Z., Hu, Q.-X., Zhang, C., Lu, W., Ni, J., Fang, Y., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.009 · Cited by 68
Leber Hereditary Optic Neuropathy: Exemplar of an mtDNA Disease
Wallace, D. C., & Lott, M. T. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_2 · Cited by 64
Engineered mitochondria in diseases: mechanisms, strategies, and applications
Li, M., Wu, L., Si, H., Wu, Y., Liu, Y., Zeng, Y., & Shen, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02081-y · Cited by 71
Medical Management of Hereditary Optic Neuropathies
Morgia, C. L., Carbonelli, M., Barboni, P., Sadun, A. A., & Carelli, V. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00141 · Cited by 62
Mitochondrial genetics and therapeutic overview of Leber's hereditary optic neuropathy
Ramasamy, S., Manickam, A., & Michael, M. (2017) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_358_17 · Cited by 59
Effect of mtDNA point mutations on cellular bioenergetics
Szczepanowska, J., Malińska, D., Wieckowski, M. R., & Duszyński, J. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.02.028 · Cited by 58
Angebault, C., Guéguen, N., Desquiret‐Dumas, V., Chevrollier, A., Guillet, V., Verny, C., Cassereau, J., Ferré, M., Miléa, D., Amati‐Bonneau, P., et al. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-557 · Cited by 57
de la Barca, J. M. C., Simard, G., Amati‐Bonneau, P., Safiedeen, Z., Mirebeau‐Prunier, D., Chupin, S., Gadras, C., Tessier, L., Guéguen, N., Chevrollier, A., et al. (2016) · Brain · doi:10.1093/brain/aww222 · Cited by 56
A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired Forms
Pilz, Y. L., Bass, S. J., & Sherman, J. (2016) · Journal of Optometry · doi:10.1016/j.optom.2016.09.003 · Cited by 56
Sieber, F., Duchêne, A., & Maréchal‐Drouard, L. (2011) · International review of cytology · doi:10.1016/b978-0-12-386043-9.00004-9 · Cited by 54
Chin, R. M., Panavas, T., Brown, J. M., & Johnson, K. K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.059 · Cited by 50
Cwerman-Thibault, H., Augustin, S., Ellouze, S., Sahel, J.-A., & Corral-Debrinski, M. (2014) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2013.11.011 · Cited by 49
Self-citationMitochondrial optic neuropathies
Carelli, V., Morgia, C. L., & Yu‐Wai‐Man, P. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-821751-1.00010-5 · Cited by 47
Gene therapy for Leber congenital amaurosis: advances and future directions
Hufnagel, R. B., Ahmed, Z. M., Corrêa, Z. M., & Sisk, R. A. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-2028-2 · Cited by 46
Yamada, Y., Somiya, K., Miyauchi, A., Osaka, H., & Harashima, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64322-8 · Cited by 44
Figueroa‐Martinez, F., Vázquez‐Acevedo, M., Cortés-Hernández, P., García‐Trejo, J. J., Davidson, E., King, M. P., & González‐Halphen, D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.09.003 · Cited by 46
Genetic manipulation for inherited neurodegenerative diseases: myth or reality?
Yu‐Wai‐Man, P. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308329 · Cited by 43
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Falabella, M., Minczuk, M. A., Hanna, M. G., Viscomi, C. F., & Pitceathly, R. D. S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00715-9 · Cited by 42
Emerging therapeutic approaches to mitochondrial diseases
Wenz, T., Williams, S. L., Bacman, S. R., & Moraes, C. T. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.109 · Cited by 42
Developments in the Treatment of Leber Hereditary Optic Neuropathy
Chen, B. S., Yu‐Wai‐Man, P., & Newman, N. J. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01246-y · Cited by 41
Pathogenesis and Treatment of Mitochondrial Disorders
DiMauro, S., & Hirano, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2813-6_10 · Cited by 39
Mitochondrial DNA replication and repair defects: Clinical phenotypes and therapeutic interventions
Roy, A., Kandettu, A., Ray, S., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148554 · Cited by 39
Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates
Calkins, D. J., Yu-Wai-Man, P., Newman, N. J., Taiel, M., Singh, P., Chalmey, C., Rogue, A., Carelli, V., Ancian, P., & Sahel, J. A. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.013 · Cited by 37
Self-citationMitochondrial complex I subunit MT-ND1 mutations affect disease progression
Lin, X., Zhou, Y., & Xue, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28808 · Cited by 40
Targeting nucleic acids into mitochondria: progress and prospects.
Niazi, A., Mileshina, D., Cosset, A., Val, R., Weber-Lotfi, F., & Dietrich, A. (2013) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2012.05.004 · Cited by 39
Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations
Cwerman‐Thibault, H., Sahel, J., & Corral‐Debrinski, M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9131-5 · Cited by 36
Self-citationAllotopic expression of mitochondrial genes: Basic strategy and progress
Artika, I. (2019) · Genes and Diseases · doi:10.1016/j.gendis.2019.08.001 · Cited by 31
RNA trafficking in plant cells: targeting of cytosolic mRNAs to the mitochondrial surface
Michaud, M., Maréchal‐Drouard, L., & Duchêne, A. (2010) · Plant Molecular Biology · doi:10.1007/s11103-010-9650-3 · Cited by 32
Zou, Y., Jia, X., Zhang, A., Wang, W., Li, S., Guo, X., Kong, Q., Zhang, Q., & Yao, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.051 · Cited by 31
Carelli, V., Newman, N. J., Yu‐Wai‐Man, P., Biousse, V., Moster, M. L., Subramanian, P. S., Vignal‐Clermont, C., Wang, A.-G., Donahue, S. P., Leroy, B. P., et al. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00611-x · Cited by 30
Self-citationGene Therapies for the Treatment of Leber Hereditary Optic Neuropathy
Sahel, J., Newman, N. J., Yu‐Wai‐Man, P., Vignal‐Clermont, C., Carelli, V., Biousse, V., Moster, M. L., Sergott, R. C., Klopstock, T., Sadun, A. A., et al. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000364 · Cited by 28
Self-citationWarburg-like effect is a hallmark of complex I assembly defects
Desquiret‐Dumas, V., Leman, G., Wetterwald, C., Chupin, S., Lebert, A., Khiati, S., Mao, M. L., Geffroy, G., Kane, M. S., Chevrollier, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.011 · Cited by 27
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
Shamsnajafabadi, H., MacLaren, R. E., & Cehajic‐Kapetanovic, J. (2023) · Cells · doi:10.3390/cells12152013 · Cited by 27
Mitochondrial disorders of the retinal ganglion cells and the optic nerve
Finsterer, J., Mancuso, M., Pareyson, D., Burgunder, J., & Klopstock, T. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.10.003 · Cited by 24
Mitochondrial genome and human mitochondrial diseases
Mazunin, I., Volodko, N. V., Starikovskaya, E. B., & Sukernik, R. I. (2010) · Molecular Biology · doi:10.1134/s0026893310050018 · Cited by 23
Zhang, K., Cao, H., Li, Y., Shan, S., Chen, J., Luo, H., Chen, W., & Huang, X. (2023) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2023.140339 · Cited by 21
Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes
Lewis, C. J., Dixit, B., Batiuk, E., Hall, C. J., O'Connor, M. S., & Boominathan, A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101429 · Cited by 20
Clinical Approaches for Mitochondrial Diseases
Hong, S., Kim, S., Kim, K., & Lee, H. (2023) · Cells · doi:10.3390/cells12202494 · Cited by 25
Trends in Mitochondrial Therapeutics for Neurological Disease
Leitão-Rocha, A., Guedes-Dias, P., Pinho, B. R., & Oliveira, J. M. A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209160317 · Cited by 19
Ding, Y., Yan, Z., Si, F., Li, X., Mao, Q., Asghar, S., & Chen, B. (2019) · Pest Management Science · doi:10.1002/ps.5579 · Cited by 18
Spiegel, S. J., & Sadun, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113205 · Cited by 18
Wang, J., Ji, Y., Ai, C., Chen, J., Gan, D., Zhang, J., Mo, J. Q., & Guan, M. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00951-1 · Cited by 17
Chin, R., Panavas, T., Brown, J. M., & Johnson, K. K. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3297-6 · Cited by 16
McGrady, N. R., Boal, A. M., Risner, M. L., Taiel, M., Sahel, J., & Calkins, D. J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.035 · Cited by 16
Self-citationMitochondrial transfection for studying organellar DNA repair, genome maintenance and aging
Mileshina, D., Ibrahim, N., Boesch, P., Lightowlers, R. N., Dietrich, A., & Weber‐Lotfi, F. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.05.002 · Cited by 16
Faria, R., Paul, M., Biswas, S., Vivès, É., Boisguérin, P., Sousa, Â., & Costa, D. R. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040757 · Cited by 17
Mitochondrial gene therapy: The tortuous path from bench to bedside
Adhya, S., Mahato, B., Jash, S., Koley, S., Dhar, G., & Chowdhury, T. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.003 · Cited by 15
Increased Protein S-Glutathionylation in Leber’s Hereditary Optic Neuropathy (LHON)
Zhou, L., Chan, J. C. Y., Chupin, S., Guéguen, N., Desquiret‐Dumas, V., Koh, S. K., Li, J., Gao, Y., Deng, L., Verma, C. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083027 · Cited by 14
Borna, N. N., Kishita, Y., Shimura, M., Murayama, K., Ohtake, A., & Okazaki, Y. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101858 · Cited by 15
Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders
Tischner, C., & Wenz, T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.06.002 · Cited by 14
Leber Hereditary Optic Neuropathy: A Mitochondrial Disease Unique in Many Ways
Bi, R., Logan, I., & Yao, Y. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_1 · Cited by 14
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics
Saravanan, S., Lewis, C. J., Dixit, B., O’Connor, M. S., Stolzing, A., & Boominathan, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020490 · Cited by 13
Gene therapies for inherited retinal disorders
Farrar, G. J., Millington‐Ward, S., Chadderton, N., Mansergh, F. C., & Palfi, A. (2014) · Visual Neuroscience · doi:10.1017/s0952523814000133 · Cited by 12
The approaches for manipulating mitochondrial proteome
Shokolenko, I. N., ALEXEYEV, M. F., LeDoux, S. P., & Wilson, G. L. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20570 · Cited by 12
Mutations in mitochondrial DNA and approaches for their correction
Patrushev, M. V., Kamenski, P. A., & Mazunin, I. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914110029 · Cited by 12
From Bench to Bedside—Delivering Gene Therapy for Leber Hereditary Optic NeuropathyPreprint
Chen, B. S., & Yu‐Wai‐Man, P. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041282 · Cited by 12
Tsai, H.-C., Hsieh, C.-H., Hsu, C.-W., Hsu, Y., & Chien, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074054 · Cited by 11
Cruz-Torres, V., Vázquez‐Acevedo, M., García-Villegas, R., Pérez-Martı́nez, X., Mendoza‐Hernández, G., & González‐Halphen, D. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.09.006 · Cited by 11
The constraints of allotopic expression
Nieto-Panqueva, F., Rubalcava-Gracia, D., Hamel, P. P., & González‐Halphen, D. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.09.004 · Cited by 9
Gene therapy for Leber hereditary optic neuropathy
Battista, M., Carelli, V., Bottazzi, L., Bandello, F. M., Cascavilla, M. L., & Barboni, P. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2359015 · Cited by 10
Rubalcava-Gracia, D., García-Rincón, J., Pérez‐Montfort, R., Hamel, P. P., & González‐Halphen, D. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-12-0788 · Cited by 10
Darbandi, S., Darbandi, M., Khorshid, H. R. K., Sadeghi, M. R., Al‐Hasani, S., Agarwal, A. K., Shirazi, A., Heidari, M., & Akhondi, M. M. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.05.006 · Cited by 8
Recent advances in delivering RNA-based therapeutics to mitochondria
Yamada, Y., Ishizuka, S., Arai, M., Maruyama, M., & Harashima, H. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2070427 · Cited by 7
Leber Hereditary Optic Neuropathy: Molecular Pathophysiology and Updates on Gene Therapy
Chi, S.-C., Cheng, H., & Wang, A.-G. (2022) · Biomedicines · doi:10.3390/biomedicines10081930 · Cited by 7
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8
Almyre, C., Bounaix, N., Godard, F., Baris, O. R., Cayer, A.-L., Sardin, E., Bouhier, M., Hoarau, A., Dard, L., Richard, J., et al. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf061 · Cited by 6
Clinical trials in mitochondrial diseases
Karaa, A., & Klopstock, T. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-821751-1.00002-6 · Cited by 6
Yamada, Y., & Harashima, H. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_650 · Cited by 6
Newman, N. J., Schniederjan, M., Mendoza, P. R., Calkins, D. J., Yu‐Wai‐Man, P., Biousse, V., Carelli, V., Taiel, M., Rugiero, F., Singh, P., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02787-y · Cited by 6
Self-citationExogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus in vivo
Begelman, D. V., Dixit, B., Truong, C., King, C. D., Watson, M. A., Schilling, B., Brand, M. D., & Boominathan, A. (2024) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2024.101372 · Cited by 5
Protein coding mitochondrial-targeted RNAs rescue mitochondrial disease in vivo
Markantone, D. M., Towheed, A., Crain, A. T., Collins, J. M., Celotto, A. M., & Palladino, M. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.009 · Cited by 5
Lyu, L., Beibei, Q. I. E., He, Y., Chen, F., & Liu, B. C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07420-3 · Cited by 4
Larin, I. I., Shatalova, R. O., Laktyushkin, V. S., Александрович, Р. С., Lapshin, E. V., Shevyrev, D., Karabelsky, A. V., Moskalets, A. P., Klinov, D. V., & Ivanov, D. A. (2024) · Polymers · doi:10.3390/polym16091187 · Cited by 4
Robert, A., Crottès, D., Bourgeais, J., Guéguen, N., Chevrollier, A., Dumas, J., Servais, S., Domingo, I., Chadet, S., Sobilo, J., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002854 · Cited by 5
Mitochondrial Genetic Manipulation
Mileshina, D., Niazi, A., Weber-Lotfi, F., Gualberto, J., & Dietrich, A. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_13 · Cited by 5
Molecular mechanisms and pathogenetic treatment of mitochondrial optic neuropathies
Nevinitsyna, T. A., & Sheremet, N. L. (2016) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2016132191-96 · Cited by 3
Mitochondrial complex I deficiency-associated diseases and models
Jentsch, L., & Ventura, N. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06169-2 · Cited by 3
Pathologies de l’ADN mitochondrial et stratégies thérapeutiques
Tonin, Y., & Entelis, N. (2014) · médecine/sciences · doi:10.1051/medsci/20143012013 · Cited by 2
Therapies Approaches in Mitochondrial Diseases
Emmanuele, V., Quinzii, C. M., & Hirano, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-70147-5_11 · Cited by 2
Mitochondrial disorders due to mutations in the mitochondrial genome
DiMauro, S., & Emmanuele, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00027-1 · Cited by 2
Metadata
- Authors
- Bonnet, C., Augustin, S., Ellouze, S., Bénit, P., Bouaita, A., Rustin, P., Sahel, J.-A., & Corral-Debrinski, M.
- Affiliations
- Institut de la Vision (FR)
- Inserm (FR)
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 1783
- Issue
- 10
- Pages
- 1707-1717
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2053558205
- Cited by
- 130
- References
- 49
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 8 · 2013: 3 · 2012: 8
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Institut Carnot Santé Animale
- Retina France
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Leber's hereditary optic neuropathy, allotopic expression, ND1 gene, ND4 gene, respiratory chain complex I, mitochondrial DNA mutations, maternally inherited mitochondrial disease, dermal fibroblasts, ATP production, fusion protein, mitochondrial protein import, gene therapy
- MeSH terms
- Adenosine Triphosphate, Adolescent, Adult, Cells, Cultured, Culture Media, Electron Transport, Fibroblasts, Galactose, Humans, Male, Mutation, NADH Dehydrogenase, Protein Binding, RNA, Messenger, Gene Expression Regulation, Enzymologic, Transgenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review